All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Not reported | 2005-000091-40 | Pivotal Study to Evaluate the Efficacy and Safety of Dermal - Living Skin Replacement (Dermal – LSR) in the Treatment of Chronic Diabetic Foot Ulcers | 2007-11-02 | due-trials |
| Not reported | 2007-003331-23 | A six-month double-blind, randomized, placebo-controlled study investigating the safety and tolerability of deferiprone in participants with Friedreich's ataxia | 2009-07-09 | due-trials |
| Listed as ongoing, but also has a completion date | 2009-010865-22 | An open-label, single treatment, safety and efficacy, long-term study of deferiprone in subjects with Friedreich's ataxia. | 2011-03-02 | bad-data |
| Reported results | 2012-000845-11 | A randomized, double-blind, placebo-controlled trial of deferiprone in patients with pantothenate kinase-associated neurodegeneration (PKAN) | 2016-10-21 | due-trials |
| Completed, but no date, and reported results Terminated | 2013-002181-39 | The efficacy and safety of Ferriprox® for the treatment of transfusional iron overload in patients with sickle cell disease or other anemias | bad-data | |
| Reported results | 2014-001427-79 | Long-term Safety and Efficacy Study of Deferiprone in Patients with Pantothenate Kinase-Associated Neurodegeneration (PKAN) | 2018-03-16 | due-trials |
| Completed, but no date, and reported results Terminated | 2014-005685-30 | Long-term safety and efficacy study of Ferriprox® for the treatment of transfusional iron overload in patients with sickle cell disease or other anemias. | bad-data | |
| Not reported | 2015-004344-19 | A Dose-Ranging Study of the Efficacy, Safety, and Pharmacokinetics of Deferiprone Delayed Release Tablets in Patients with Parkinson’s Disease | 2019-09-04 | due-trials |
| Completed, but no date | 2018-004016-22 | Safety and acceptability of deferiprone delayed release tablets in patients with systemic iron overload Ασφάλεια και επίπεδο αποδοχής των δισκίων δεφεριπρόνης καθυστερημένης αποδέσμευσης από ασθεν... | bad-data |